Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-based assay for beta-secretase activity.

Myungsok Oh1, Sung Yun Kim, Yeong Soo Oh

  • 1Department of Life Science and National Research Laboratory of Proteolysis, Kwangju Institute of Science and Technology, 500-712 Kwangju, South Korea.

Analytical Biochemistry
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secretory form of viral protease NIa ameliorates amyloid-β pathology and cognitive deficits in a mouse model of Alzheimer's disease.

Frontiers in aging neuroscience·2026
Same author

The matricellular protein CCN5 (WISP2) inhibits cellular senescence in cardiac myoblasts and fibroblasts.

Scientific reports·2026
Same author

Circular RNA circSmad4 controls pulmonary fibrosis.

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology·2026
Same author

Intratracheal Delivery of a Phospholamban Decoy Peptide Attenuates Cardiac Damage Following Myocardial Infarction.

International journal of molecular sciences·2025
Same author

Widespread regulation of the maternal transcriptome by Nanos in Drosophila.

PLoS biology·2024
Same author

Molecular Design of Encapsulin Protein Nanoparticles to Display Rotavirus Antigens for Enhancing Immunogenicity.

Vaccines·2024
Same journal

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

Analytical biochemistry·2026
Same journal

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Analytical biochemistry·2026
Same journal

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Analytical biochemistry·2026
Same journal

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

Analytical biochemistry·2026
Same journal

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

Analytical biochemistry·2026
Same journal

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Analytical biochemistry·2026
See all related articles

A new cell-based assay effectively monitors beta-secretase (BACE) activity, crucial for Alzheimer's disease research. This method screens inhibitors, identifying effective treatments by detecting BACE

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Amyloid beta-peptide (Abeta) deposition in the brain is a key factor in Alzheimer's disease (AD) pathogenesis.
  • Beta-secretase (BACE) initiates Abeta generation by cleaving amyloid precursor protein (APP), making it a therapeutic target.

Purpose of the Study:

  • To develop and validate a cell-based assay for monitoring BACE activity.
  • To assess the efficacy of protease inhibitors against BACE in a cellular context.

Main Methods:

  • A fusion protein comprising a Golgi-resident transmembrane domain, a beta-site cleavage sequence, and alkaline phosphatase (AP) was expressed in Drosophila S2 cells.
  • Cleavage of the fusion protein by BACE releases AP into the culture medium, allowing for detection and quantification.

Related Experiment Videos

  • Three peptidomimetic inhibitors (LB83190, LB83192, LB83202) were tested using the cell-based assay.

    • Main Results:

    • The assay successfully detected BACE activity through the release of AP.
    • LB83190 and LB83192 demonstrated effective inhibition of BACE activity.
    • LB83202 showed no inhibition, likely due to its inability to cross the cell membrane.

    Conclusions:

    • The developed cell-based assay is a viable tool for monitoring BACE activity.
    • This assay facilitates high-throughput screening of potential BACE inhibitors for Alzheimer's disease therapeutics.
    • Cellular permeability is a critical factor for the efficacy of BACE inhibitors.